Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02960555
Title Trial of Isatuximab (SAR650984) in Patients With High Risk Smoldering Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

smoldering myeloma

Therapies

Diphenhydramine + Isatuximab + Methylprednisolone + Ranitidine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.